N-Acetylglucosaminyltransferases
"N-Acetylglucosaminyltransferases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enzymes that catalyze the transfer of N-acetylglucosamine from a nucleoside diphosphate N-acetylglucosamine to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-.
| Descriptor ID |
D017351
|
| MeSH Number(s) |
D08.811.913.400.100.250
|
| Concept/Terms |
N-Acetylglucosaminyltransferases- N-Acetylglucosaminyltransferases
- N Acetylglucosaminyltransferases
- N-Acetylglucosamine Transferases
- N Acetylglucosamine Transferases
- Transferases, N-Acetylglucosamine
|
Below are MeSH descriptors whose meaning is more general than "N-Acetylglucosaminyltransferases".
Below are MeSH descriptors whose meaning is more specific than "N-Acetylglucosaminyltransferases".
This graph shows the total number of publications written about "N-Acetylglucosaminyltransferases" by people in this website by year, and whether "N-Acetylglucosaminyltransferases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 1 | 2 |
| 2020 | 2 | 0 | 2 |
| 2023 | 1 | 0 | 1 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "N-Acetylglucosaminyltransferases" by people in Profiles.
-
O-GlcNAcylation as a Metabolic Integrator in Cardiovascular Physiology and Disease. Int J Mol Sci. 2026 May 22; 27(11).
-
N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on a-dystroglycan and prevents muscular dystrophy. Elife. 2023 02 01; 12.
-
POMK regulates dystroglycan function via LARGE1-mediated elongation of matriglycan. Elife. 2020 09 25; 9.
-
Predominant and novel de novo variants in 29 individuals with ALG13 deficiency: Clinical description, biomarker status, biochemical analysis, and treatment suggestions. J Inherit Metab Dis. 2020 11; 43(6):1333-1348.
-
Glycosylation of Specific Notch EGF Repeats by O-Fut1 and Fringe Regulates Notch Signaling in Drosophila. Cell Rep. 2019 11 12; 29(7):2054-2066.e6.
-
In vivo CRISPR screening in CD8 T cells with AAV-Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma. Nat Biotechnol. 2019 Nov; 37(11):1302-1313.
-
Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1. Cancer Cell. 2018 02 12; 33(2):187-201.e10.
-
Mapping Sites of O-Glycosylation and Fringe Elongation on Drosophila Notch. J Biol Chem. 2016 07 29; 291(31):16348-60.
-
Mutations in POMGNT1 cause non-syndromic retinitis pigmentosa. Hum Mol Genet. 2016 Apr 15; 25(8):1479-88.
-
Fringe proteins modulate Notch-ligand cis and trans interactions to specify signaling states. Elife. 2014 Sep 25; 3:e02950.